Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
Elcin Suren, Ersan Cetinkaya, Mustafa Kalayci and 3 more
Case Reports in Ophthalmological Medicine · 2020
doi:10.1155/2020/8861435 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
We report the case of a male infant who had an intravitreal anti-VEGF (aflibercept) injection for the treatment of retinopathy of prematurity at 35-week postmenstrual age. Four days following the injection, retinal imaging demonstrated a yellowish gray blurred mass that extended into the vitreous in the right eye, and the vitreous body was blurred. After two days, despite starting endophthalmitis treatment, there was still no improvement in the retinal lesion. Due to the worsening of the clinical signs, we decided to perform 25-gauge lens-sparing pars plana vitrectomy.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.